Vimarsana
Biggest News Aggregation in the World

Ronaldm Benoit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ronaldm Benoit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ronaldm Benoit Today - Breaking & Trending Today

Perspective Therapeutics' Cesium-131 to be Featured in Presentations at the 2023 American Brachytherapy Society's Annual Meeting - Vimarsana News

Perspective Therapeutics' Cesium-131 to be Featured in Presentations at the 2023 American Brachytherapy Society's Annual Meeting

Published: June 16, 2023

Cesium-131 brachytherapy in the treatment of prostate cancer will be highlighted in two presentations at the meetingRICHLAND, Wash & CORALVILLE, IOWA, June 16, 2023 --   Perspective... | June 16, 2023

Source: marketscreener.com
Related Topics:
United StatesBritish ColumbiaUnited KingdomRonaldm BenoitMohammeda MohammedThijs SpoorBryanp SmithSushil BeriwalAmerican Brachytherapy SocietyUniversity Of Pittsburgh Medical CenterDepartment Of Radiation OncologyPerspective Therapeutics IncHillman Cancer CenterPerspective TherapeuticsBrachytherapy SocietyAnnual MeetingPerspective Therapeutic Chief ExecutiveRadiation OncologyLong Term Results ComparedProstate ProfferedPittsburgh Medical CenterStereotactic Body Radiation TherapyIsotopes Are Not Created EqualDoes One StandProstate Session
Study Finds Excellent Outcomes for Intermediate Risk - Vimarsana News

Study Finds Excellent Outcomes for Intermediate Risk

Published: March 2, 2022

RICHLAND, Wash., March 02, 2022 (GLOBE NEWSWIRE) -- Investigators from the University of Pittsburgh School of Medicine have published a clinical study...

Source: globenewswire.com
Related Topics:
United StatesSushil BeriwalAnkurk PatelBryanp SmithJoshual RodrRonaldm BenoitSchool Of MedicineAmerican Brachytherapy SocietyUniversity Of Pittsburgh School MedicineUniversity Of PittsburghPittsburgh SchoolAmerican BrachytherapyNyse Isr
Study Finds Excellent Outcomes for Intermediate Risk Prostate Cancer Patients Treated with Isoray's Cesium-131 - Vimarsana News

Study Finds Excellent Outcomes for Intermediate Risk Prostate Cancer Patients Treated with Isoray's Cesium-131

Published: March 2, 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Related Topics:
United StatesSushil BeriwalMark LevinSharon SchultzAnkurk PatelBryanp SmithJoshual RodrRonaldm BenoitSchool Of MedicineUniversity Of Pittsburgh School MedicineIsoray Medical IncAmerican Brachytherapy SocietyUniversity Of PittsburghIsoray IncPittsburgh SchoolAmerican BrachytherapyIsoray MedicalCesium BluPrivate Securities Litigation Reform ActPublic RelationsGlobe NewswireProstate Cancer